William Richards, Theresa Carbonaro, Katherine Bonson
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Resurgence in psychedelic assisted psychotherapy (PAP) shows promise in treating mental illnesses, integrating psilocybin with Psychohistoriographic Brief Therapy (PBT) in a structured treatment protocol. Caribbean programs must prioritize safety and
Winston De La Haye
Psychedelic drugs may enhance creative thinking and empathy, supported by anecdotal reports and some scientific evidence. Studies show time- and construct-dependent effects on flexible cognition, with brain imaging linking changes
Natasha Mason
Roland Griffiths, Ph.D., from Johns Hopkins University, leads research on psilocybin's effects, including therapeutic studies for psychological distress, depression, addiction, and brain imaging for neural mechanisms.
Roland Griffiths
Robin Carhart-Harris, Head of Centre for Psychedelic Research at Imperial College London, conducted pioneering clinical studies with psilocybin and other psychedelic drugs for over 40 years. He collaborates with Professor
Dr. Sloshower presents results from a psilocybin-assisted therapy study for major depression, showing larger antidepressant effects than placebo, with lasting mood improvements. Dr. Kilpatrick discusses longitudinal case studies.
Jordan Sloshower, Stephanie Kilpatrick
Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.
Paul Summergrad, Tom Insel, Rachel Nuwer
Funding for psychedelic medicine is evolving, with a rise in commercial capital alongside philanthropic support. Balancing financial interests with equitable access and learning from scaling challenges are key considerations.
Henry Elkus
Rick Doblin discusses growing up with the "queen of psychedelics", Rock and Cosmo's paths to this work, challenges of working with family, and their shared vision for the psychedelic renaissance.
Amanda Feilding, Rock Feilding-Mellen, Cosmo Fielding Mellen
Dr. Fadiman shares insights from personal psychedelic experiences and interactions with key pioneers, highlighting how psychedelics influence his Integrative Medicine philosophy and potential for global impact.
Andrew Weil
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.